Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

El.En. Investor Presentation 2022

Nov 22, 2022

4393_cp_2022-11-22_e70b6b32-a667-4312-9eab-d42a203f4486.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

COMPANY PRESENTATION

Intermonte

November 23rd, 2022

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forwardlooking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forwardlooking statements. The Company undertakes no obligation about the contents nor to update the forwardlooking statements to reflect events or circumstances thatmay arise after the date hereof.

1.Overview 2.Markets and Growth drivers 3.Innovation: products & applications 4.FDA clearance for Accure laser 5.Financial Highlights 6.Current Outlook 7.Multiples & Comparables

OVERVIEW

World Class Hi-Tech company

Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 40 years

Listed on Milan's Stock Exchange Star segment since year 2000 and member of Euronext Tech Leaders

Within Worldwide leaders in its space

Active worldwide on several laser application segments andmarkets…

…progressively widening its worldwide presence achieving continuous growth over the years

WE CREATE LIGHT,ENERGY,WAVES

MEDICAL

Our energy based systems improvepeople's well-being and life quality.

In the SURGICAL SECTOR, our minimally invasive technology systems minimize pain, side effects and risks of surgical procedures and hospitalization days.

In the AESTHETIC SECTOR, our systems satisfy the growing desire of individuals to improve their appearance also reducing pathological or painful imperfections.

INDUSTRIAL

Our LASER CUTTING and MARKING SYSTEMS Improve the productivity of our customers manufacturing plants also limiting the environmental impact of manufacturing processes minimizing waste, fumes generated by the process, use of chemical additives, and allowing to eliminate the need for inks, solvents or glues within the process.

CONSERVATION

Our LASER SYSTEMS PRESERVE artworks of the universal heritage of our communities.

10%

from renewable

Self-generated

energy

sources

or

7

ENVIRONMENT2

Photovoltaic systems active in 21

4New plants planned in 22

OUR HISTORY

80s

Production of CO2 lasers for dermatology,surgery and therapy

1981

Incorporation of El.En.S.n.c

Development of short pulse Nd:YAG lasers for dentistry and minimally invasive surgery treatments

1990 - 1993

Incorporation of Deka MELA S.r.l., Lasit S.p.A.eCutlite Penta S.r.l.

1998

Smartepil (Deka Mela S.r.l.) - first long pulse Nd:Yag laser for dermatology and hair removal

2000

El.En.S.p.A.listed on the italian stock market

2002

Smartlipo (Deka Mela S.r.l.laserlipolisi®: localized removal of adipose deposits with minimally invasive treatment

Acquisition of Cynosure Inc.

2003

Smartxide DOT® Therapy (Deka Mela S.r.l.) dermatological surgery, anti-aging treatments,removal of pigmented lesions and scars

Acquisition of Asclepion GmbH

2004

Acquisition of Quanta System

2005

Acquisition of Asa

Cynosure IPO on Nasdaq

2007

Incorporation of a JV in China: Wuhan Penta Chutian Co.Ltd

Incorporation of Cutlite Do Brasil Alta Tecnologia Ltda

2008

Mediostar XT (Asclepion GmbH) esthetics and hair removal.

Industrial sector El.En.– creation of the BLADE RF CO2BLADE RFlaser sources family

Litho (Quanta System S.p.A.) surgical, treatment of kidney stones

2009

Plus RF (Cutlite Penta S.r.l.) with RF El.En. sources for metacrilate and wood cutting systems

Incorporation of Esthelogue S.r.l.

2010

Smartxide2 (Deka Mela S.r.l.) laser system with CO2 radio frequency (RF) laser sources for dermatological surgery and aesthetics

2011

Mediostar Next (Asclepion GmbH) aesthetics, hair removal

OUR HISTORY

2012

Monna Lisa TouchTM (Deka Mela S.r.l.) for the treatment of vaginal atrophy

Cyber (Quanta System S.p.A.) surgery, Lithotripsy and BPH

2013

Incorporation of second JV Penta Laser Equipment (Wenzhou) Co.Ltd

2016

Motus AX with Moveo (Deka Mela S.r.l.) hair removal,removal of pigmented lesions

Juliet® (Asclepion GmbH) for the treatment of vaginal atrophy

Deka M.E.L.A.S.r.l.and Quanta System S.p.A.join their commercial brand names into Reinassance® for the Italian market

2019

The Chinese subsidiary Penta Laser Equipment (Wenzhou) Co.Ltd incorporates Penta Laser Technology (Shangdong) Co.Ltd

Acquisition by Quanta System of Galli S.r.l. a precision mechanical components manufacturing facility.

2015

Bolt (Penta Chutian e Wenzhou - China) enhanced system for laser metal cutting

Discovery Pico (Quanta System S.p.A.) tattoo and pigmented lesions removal and dermatological treatments

HIRO TT (ASA S.r.l.) painful pathologies of the muscle and skeleton

Fiber Plus (Cutlite Penta S.r.l.) first metal cutting laser system equipped with fiber laser source

2017

Industrial sector RF 1222 CO2 RF laser source "The Big Boy"

2018

ONDA Coolwaves®(Deka Mela S.r.l.) the first microwaves technology system for body contouring

2020

Schwarzy (magnetotherapy) Red Touch (dermatology) Again (hair removal) Dr.Arnold(magnetotherapy)

2021

Lasit Laser Polska incorporated by Lasit in Poland

Glide (dermatology) Chrome Laser Station(dermatology)

9

EL.EN. WORLDWIDE

MARKETS AND GROWTH DRIVERS

LASER SURGERY MARKET TRENDS

MINIMALLY INVASIVE SURGERIES:

  • Painless procedures
  • Lower risks and side effects
  • Shorter hospital stays/Faster recovery
  • Savings by Private & National Health Systems
  • Attractive ROI for surgical services providers

•Mordor intelligence: 5,51% 2019-2027 CAGR from \$1Bn in 2020

MEDICAL AESTHETICS MARKET TRENDS

  • Aging demographics and increasing focus on improving appearance and youthfulness;
  • Growing interest in non-invasive or minimally invasive procedures and awareness of energybased aesthetic treatments
  • Growing global obesity rate
  • Reductions in procedure costs, attracting a broader patient base
  • Normalization and social acceptance of cosmetic procedures
  • Rapid growth expected:
k
D
i
i
M
R
t
t
e
c
s
o
n
a
r
e
e
p
o
r
s		 C
A
G
R
1
6,
5
%
2
0
2
7
t
o
l
D
i
A
i
t
a
n
e
s
s
o
c
a
e
s		 C
A
G
R
1
0,
2
3
2
0
2
3
t
o
h
F
B
i
I
i
t
t
o
r
u
n
e
u
s
n
e
s
s
n
s
g
s		 C
A
G
R
1
3,
9
2
0
2
7
t
o
d
l
l
M
I
i
t
o
r
o
r
n
e
g
e
n
c
e		 C
A
G
R
1
1,
0
8
%
2
0
2
6
t
o

INDUSTRIAL LASER MARKET TREND

Laser cutting applications:

  • Laser power increase + Cost reduction: enhanced flexibility, productivity and quality standards in manufacturing processes
  • New application verticals
  • Building and construction

Laser marking:

  • Products identification and traceability
  • Minimal environmental impact

INNOVATION: PRODUCTS & APPLICATIONS

HAIR REMOVAL DEVICES

Again

18

BODY CONTOURING DEVICES

SKIN DEVICES

Discovery Pico Smart Pico

Unique high end system for laser tattoo removal

Luxea

The ultimate multi application and multi technology platform

RED Touch

The system for neocollagenesis and tissue regeneration

One of the main worldwide players in high power medical fiber lasers

Our novel disruptive technology for the most effective stones micro fragmentation

MONALISA TOUCH GLIDE - DUOGLIDE

Novel CO2 device for dermatology and gynecology featuring an additional 1540nm laser source

PHYSIOTHERAPY

MiS (MLS Family) For degenerative neuropathies

INDUSTRIAL LASERS SYSTEMS

STEEL CUTTING

  • 12 kW Average power in 2022 sales

  • 40 kW systems installed in 2022

LASER CUTTING SYSTEMS OFFER IN CHINA

-

-

FDA CLEARANCE FOR ACCURE LASER

FDA Clears the revolutionary Accure Laser

  • Disruptive technology with active IP portfolio in the vast, global acne market
  • Positive safety profile & clinical results; non-drug based with expected durable outcomes
  • World-class team: Dr. Rox Anderson: Co-Founder; Chief Scientific & Medical Officer

• CE Marked

FDA Clears the revolutionary Accure Laser

FDA Clears the revolutionary Accure Laser

FINANCIAL HIGHLIGHTS

INCOME STATEMENT – 9 M 2022

'0
E
0
0
r
o
u		 /
/
3
0
0
9
2
1		 % /
/
3
0
0
9
2
2		 % %
V
a
r.
d
d
i
t
n
a
e
u
u		 d
d
i
t
n
a
e
u
u
d
l
M
i
e
a
c		 2
2
0
4
7
6		 5
4,
4
%		 2
7
0
5
2
9		 5
5,
9
%		 2
2,
7
%
d
l
i
I
t
n
u
s
r
a		 1
8
4
8
2
4		 %
4
5,
6		 2
1
3
8
2
0		 %
4
4,
1		 %
1
5,
7
R
e
v
e
n
u
e
s		 0
3
0
0
4
5		 0
0
0
%
1
,		 8
3
8
4
4
4		 0
0
0
%
1
,		 9
%
1
5
,
i
G
r
o
s
s
m
a
r
g
n		 1
0
2
0
3
5		 3
1
%
7
,		 1
9
4
9
6
7		 3
1
%
7
,		 1
9
%
5
,
O
i
E
t
p
e
r
a
n
g
x
p
e
n
s
e
s		 3
3
9
8
4		 8
4
%
,		 4
1
5
1
1		 8
6
%
,		 2
2
1
%
,
f
f
S
t
a
e
s
p
e
n
s
e
s		 6
0
5
5
6		 %
1
4
9
,		 7
0
4
2
1		 %
1
4
5
,		 %
1
6
3
,
E
B
I
T
D
A		 6
6
3
5
5		 3
%
1
7
,		 6
6
7
5
4		 3
9
%
1
,		 2
%
1
4
,
l
D
t.
e
p
r.
a
m
o
r
a
c
c
r
u
a
s
,
,		 0
8
6
1
1		 2
%
7
,		 9
6
0
4		 2
0
%
,		 3
0
%
1
-
,
E
B
I
T		 4
4
5
7
7		 0
%
1
1
,		 9
2
5
7
4		 2
0
%
1
,		 2
9
9
%
,
f
(
)
h
N
i
i
t
e
n
a
n
c
n
c
o
m
e
c
a
r
g
e
s		 1
1
5
6		 0
3
%
,		 (
)
7		 0
0
%
,
h
(
)
O
i
t
t
e
r
n
c
o
m
e
e
x
p
e
n
s
e
n
e		 (
)
1
7
1		 %
0
0
,		 3 %
0
0
,
E
B
T		 4
5
5
6
2		 %
1
1
2
,		 5
7
9
2
0		 %
1
2
0
,		 %
2
7
1
,
/
/
3
1
1
2
2
1		 /
/
3
0
0
9
2
2
d
d
i
t
u
n
a
u
e
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 1
1
5
7
6
6		 3
2
0
0
7		 3
1

CASH FLOW

32

REVENUE BREAKDOWN BY AREA

34

CURRENT OUTLOOK

MULTIPLES & COMPARABLES

MULTIPLES

k
h
l
d
's
h
S
i
E
t
t
o
c
o
e
r
q
u
y
p
e
r
s
a
r
e		 0
4
,
/
k
l
d
i
j.
P
B
V
A
r
c
e
o
o
a
u
e		 3,
5
/
(
)
E
V
E
B
I
T
9
0
%
E
B
I
T		 1
5,
0
/
(
)
l
l
E
V
S
9
0
%
S
a
e
s
a
e
s		 1,
8
l.
k
C
E
E
M
t
n
a
r
e
a
p		 1
0
9
1
5,		 @ €
1
3,
2
7
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 3
2,
0		 @ /
/
3
0
0
9
2
2
/
l
l
i
i
i
F
t
t
t
n
a
n
c
a
n
e
s
m
e
n
s
m
e
r
m
v		 2
1,
4		 @ /
/
3
0
0
9
2
2
l
i
E
V
t
n
e
r
p
r
s
e
a
u
e		 1
0
4
1,
7

h ,
Se
3
0
2
0
2
2
t.
t
p
/
d
l
he
M
ica
Ae
ic
t
t
e
s		 ice
Pr		 Re
ve
nu
e		 %
Va
r.
Re
v.		 E
B
I
T		 %
E
B
I
T		 Ca
M
K.
p.		 E
V		 /
Sa
le
E
V
s
(
*)		 /
E
V
E
B
I
T
(
*)		 /
k
P
Bo
o
lu
Va
e
Cu
te
ra		 \$
4
4,
4
9		 \$
1
8
5		 2
7
%		 \$
(
)
3
3		 -1
8
%		 \$
8
7
1		 \$
9
3
5		 3,
8		 n.
a.		 5
6,
2
de
In
M
o		 \$
3
7,
5
2		 \$
3
2
1		 3
0
%		 \$
1
3
8		 4
3
%		 \$
3.
1
2
0		 \$
2.
6
3
7		 6,
2		 1
4,
4		 6,
1
Ve
nu
s		 \$
0,
2
2		 \$
7
5		 3
%		 \$
(
)
2
6		 -3
5
%		 \$
1
5		 \$
8
5		 0,
9		 n.
a.		 1,
6
(
)
isr
d
ica
l
S
M
2
am
e		 \$
1,
0
3		 \$
1
7
5		 3
9
%		 \$
2
4		 1
4
%		 \$
4
8
0		 \$
3
7
1		 1,
1		 7,
7		 1,
2
ic
(
)
Lu
2
tro
n		 €
1
3,
3
2		 €
8
9		 5
4
%		 €
1
9		 2
1
%		 €
3
5
5		 €
2
9
9		 1,
7		 7,
9		 3,
5
du
l
In
ia
tr
s
ho
ics
I
P
G
P
Co
to
n		 \$
9
4,
6
3		 \$
1.
0
9
6		 0
%		 \$
2
5
8		 2
4
%		 \$
4.
6
1
0		 \$
3.
4
7
8		 2,
4		 1
0,
1		 1,
8
im
du
ie
Pr
In
tr
a
s		 €
2
4,
7
0		 €
3
2
7		 1
5
%		 €
1
4		 4
%		 €
2
5
9		 €
3
3
9		 0,
8		 1
8,
8		 1,
4
's
Ha
La
n
se
r		 ¥
2
6,
9
2		 ¥
1
0.
4
9
0		 %
-1
2		 ¥
5
3
8		 %
5		 ¥
2
8.
6
4
0		 ¥
2
8.
9
0
6		 2,
1		 4
0,
4		 2,
0
(
)
ic
By
2
tr
s
on		 C
H
F
6
5
1		 C
H
F
4
5
3		 %
3		 C
H
F
1
1		 %
2		 C
H
F
1.
1
9
0		 C
H
F
7
5
0		 0,
8		 3
5,
7		 1,
7
l.
(
)
E
En
1		 €
3,
2
1
7		 €
8
4
4		 2
0
%		 €
8
5		 2
%
1		 €
0
9
1.
5		 €
0
2
1.
4		 8
1,		 0
1
5,		 3,
5

(1) EV and multiplies as for previous slide

(2) Financials on June 30th, 2022

(*) Revenue,Ebit and earnings annualized

COMPARABLES

CONTACTS

El.En. S.P.A. Enrico Romagnoli Investor Relations Manager tel. +39 055-8826807 E-mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press Office Bianca Fersini Mastelloni - [email protected] Silvia Marongiu - [email protected] Tel. +39 06-69923324

More from El.En.

Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 28
Interim / Quarterly Report 2026
May 26
Governance Information 2026
May 26
AGM Information 2026
May 26
Report Publication Announcement 2026
May 26
Report Publication Announcement 2026
May 26
Investor Presentation 2026
May 18
Investor Presentation 2026
May 18
Report Publication Announcement 2026
May 18
View all filings →